cysteine has been researched along with Epithelial Ovarian Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, CY; Lei, MZ; Lei, QY; Li, JT; Li, KY; Lu, HJ; Pei, X; Qu, J; Shen, Y; Wen, W; Yang, HJ; Yin, M | 1 |
| Chen, J; Chen, M; Huang, X; Liu, J; Shangguan, M; Wang, T; Wu, S; Yang, Z; Zhang, C; Zhao, S | 1 |
2 other study(ies) available for cysteine and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
Palmitoylation of MDH2 by ZDHHC18 activates mitochondrial respiration and accelerates ovarian cancer growth.
Topics: Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cysteine; Female; Glutamine; Humans; Lipoylation; Malate Dehydrogenase; Ovarian Neoplasms; Respiration; Tricarboxylic Acids | 2022 |
Gomisin A enhances the antitumor effect of paclitaxel by suppressing oxidative stress in ovarian cancer.
Topics: Animals; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Complex Mixtures; Cyclin B1; Cyclin-Dependent Kinase 4; Cyclooctanes; Cysteine; Dioxoles; Eosine Yellowish-(YS); Female; Humans; Lignans; Mice; Ovarian Neoplasms; Oxidative Stress; Paclitaxel; Reactive Oxygen Species | 2022 |